2017
R&D investment behavior of US pharmaceutical firms
JIRÁSEK, MichalZákladní údaje
Originální název
R&D investment behavior of US pharmaceutical firms
Autoři
JIRÁSEK, Michal (203 Česká republika, garant, domácí)
Vydání
International Journal of Innovation Science, EMERALD GROUP PUBLISHING LTD, 2017, 1757-2223
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
50600 5.6 Political science
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Kód RIV
RIV/00216224:14560/17:00096812
Organizační jednotka
Ekonomicko-správní fakulta
UT WoS
000412571600007
Klíčová slova anglicky
Innovation management; R&D investment; Behavioral theory of the firm; US pharmaceutical firms
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 12. 1. 2024 13:20, Mgr. Pavlína Kurková
Anotace
V originále
Purpose – The behavioral theory of the firm (BTOF) has been used to explain the research and development (R&D) investment behavior of firms in numerous multi industry studies. However, their partially contradictory results point to the possible need for a single industry perspective that would reduce heterogeneity of business trends, models and other characteristics. This study aims to test this theoretical assumption within the challenging context of the US pharmaceutical industry. Design/methodology/approach – The research uses data from 20 firms, which number among the largest in the US pharmaceutical industry, over the period 2002-2014. These data are analyzed using fixed- and random-effect panel models. Findings – The findings generally support the need for a thorough understanding of the industry under study and its specific characteristics. The firms analyzed in this research behave slightly differently from theoretical assumptions, and it is argued that this is caused by industry specific factors. Moreover, the use of two separate aspiration measures – for historical and social aspirations – is supported as it provides more in-depth insight into the firms’ behavior.
Návaznosti
MUNI/A/0909/2015, interní kód MU |
|